Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 32: Telmisartan - Losartan - HCTZ Abb. 33: Telmisartan - Losartan - HCTZ Abb. 34: Telmisartan - Valsartan - HCTZ Aktuelles Bild - Abb. 35: Telmisartan - HCTZ Abb. 36: Telmisartan - HCTZ Abb. 37: Telmisartan - HCTZ - Diabetes Abb. 38: Telmisartan - HCTZ Zum letzten Bild
Abbildung 35: Telmisartan - HCTZ
This study, A comparison of Telmisartan plus HCTZ with amlodipine plus HCTZ in Older patients with predominantly Systolic hypertension (ATHOS) compared telmisartan 40–80 mg + HCTZ 12.5 mg with amlodipine 5–10 mg + HCTZ 12.5 mg.1 On entry, the patients had seated SBP >140 mmHg, seated DBP ≤95 mmHg and 24-h mean ambulatory SBP 125 mmHg. They were elderly (≥60 years old). The primary endpoint, the change from baseline in SBP in the last 6 h of the dosing interval, was not significantly different between the two groups. However, SBP was significantly reduced with telmisartan + HCTZ compared with amlodipine + HCTZ over the 24 h, morning and daytime periods. SBP control rates (24-h mean SBP <140 mmHg) were also significantly greater (p=0.0175) with telmisartan + HCTZ (65.9%) than with amlodipine + HCTZ (58.3%). 1. Data on file. Boehringer Ingelheim, GmbH.
 
Telmisartan - HCTZ
Vorheriges Bild Nächstes Bild   


Abbildung 35: Telmisartan - HCTZ
This study, A comparison of Telmisartan plus HCTZ with amlodipine plus HCTZ in Older patients with predominantly Systolic hypertension (ATHOS) compared telmisartan 40–80 mg + HCTZ 12.5 mg with amlodipine 5–10 mg + HCTZ 12.5 mg.1 On entry, the patients had seated SBP >140 mmHg, seated DBP ≤95 mmHg and 24-h mean ambulatory SBP 125 mmHg. They were elderly (≥60 years old). The primary endpoint, the change from baseline in SBP in the last 6 h of the dosing interval, was not significantly different between the two groups. However, SBP was significantly reduced with telmisartan + HCTZ compared with amlodipine + HCTZ over the 24 h, morning and daytime periods. SBP control rates (24-h mean SBP <140 mmHg) were also significantly greater (p=0.0175) with telmisartan + HCTZ (65.9%) than with amlodipine + HCTZ (58.3%). 1. Data on file. Boehringer Ingelheim, GmbH.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung